229 related articles for article (PubMed ID: 21674475)
1. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
[TBL] [Abstract][Full Text] [Related]
2. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
3. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
[TBL] [Abstract][Full Text] [Related]
4. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
[TBL] [Abstract][Full Text] [Related]
5. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
6. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells.
Tigno-Aranjuez JT; Jaini R; Tuohy VK; Lehmann PV; Tary-Lehmann M
J Immunol; 2009 Nov; 183(9):5654-61. PubMed ID: 19812193
[TBL] [Abstract][Full Text] [Related]
7. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.
Graham KL; Zabel BA; Loghavi S; Zuniga LA; Ho PP; Sobel RA; Butcher EC
J Immunol; 2009 Nov; 183(10):6717-23. PubMed ID: 19864606
[TBL] [Abstract][Full Text] [Related]
8. EAE mediated by a non-IFN-γ/non-IL-17 pathway.
Kroenke MA; Chensue SW; Segal BM
Eur J Immunol; 2010 Aug; 40(8):2340-8. PubMed ID: 20540117
[TBL] [Abstract][Full Text] [Related]
9. Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Mangalam AK; Luckey D; Giri S; Smart M; Pease LR; Rodriguez M; David CS
J Autoimmun; 2012 Jun; 38(4):344-53. PubMed ID: 22459490
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2.
Leavenworth JW; Schellack C; Kim HJ; Lu L; Spee P; Cantor H
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2562-7. PubMed ID: 20133787
[TBL] [Abstract][Full Text] [Related]
11. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
Peng Y; Liu CP
Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
[TBL] [Abstract][Full Text] [Related]
13. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
[TBL] [Abstract][Full Text] [Related]
14. RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
Sinha S; Miller LM; Subramanian S; Burrows GG; Vandenbark AA; Offner H
PLoS One; 2011; 6(7):e21868. PubMed ID: 21750737
[TBL] [Abstract][Full Text] [Related]
15. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads.
Tanaka K; Ichiyama K; Hashimoto M; Yoshida H; Takimoto T; Takaesu G; Torisu T; Hanada T; Yasukawa H; Fukuyama S; Inoue H; Nakanishi Y; Kobayashi T; Yoshimura A
J Immunol; 2008 Mar; 180(6):3746-56. PubMed ID: 18322180
[TBL] [Abstract][Full Text] [Related]
16. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.
Hofstetter HH; Kovalovsky A; Shive CL; Lehmann PV; Forsthuber TG
J Neuroimmunol; 2007 Jul; 187(1-2):20-30. PubMed ID: 17482277
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
[TBL] [Abstract][Full Text] [Related]
18. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
19. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
[TBL] [Abstract][Full Text] [Related]
20. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
